Gene Query: UBE2I

Dataset Description Geneva Score
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 41.24
UBC9 knockdown in bladder cancer T24 cell lines 36.09
Cleavage Factor Im as a key regulator of 3’ UTR length 35.41
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 31.28
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 25.95
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 21.38
A role for ZNF598 in post-transcriptional gene regulation 20.26
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 18.69
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 18.64
Targeting EZH2 in MYCN-amplified Neuroblastoma 18.64
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 17.12
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 15.14
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.95
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 14.76
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 14.58
The interplay between SOX4 and SMAD3 in the context of breast cancer 13.89
RNA-seq of IL-4 stimulated human keratinocytes 13.61
Global analysis of enhancer targets: Mosaic-seq 13.41
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 13.07
Role of microRNAs in the interaction between Salmonella and the host cell 13.07
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 12.69
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 12.63
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.36
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 12.32
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 12.25
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 12.25
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.05
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 11.89
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 11.89
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 11.75
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 11.72
HNRNPL and its RNA Targets in Prostate Cancer 11.72
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 11.72
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.63
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 11.58
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 11.58
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.47
Gene Expression Profiling of SPOP Knocked Down Cell 11.37
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.32
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.29
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 11.05
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.95
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.51
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.51
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 10.47
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 10.47
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.26
CROP-Seq in Primary Human T Cells 10.0
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.99
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 9.79
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 9.76
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 9.67
RNA polymerase in pre-B-ALL cell lines 9.67
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 9.61
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.3
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 9.18
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.15
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.15
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 9.13
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 9.13
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.1
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.09
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 9.06
Expression profiling of MCF-7 cells with treatment of TCDD 9.06
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.05
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.87
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 8.64
Studying the selectivity of a small molecule Synucleozid on transcriptome 8.63
hnRNP C is a key regulator of protein synthesis in mitosis 8.62
The comparison of high-throughput single-cell RNA-seq methods 8.6
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.54
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.5
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.48
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.48
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 8.42
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 8.42
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 8.4
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.4
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 8.35
Neurofibroma 8.35
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 8.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 8.34
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.21
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.21
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 8.2
RNA seq comparison between scrambled and shGRP78 cells 8.16
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 7.96
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 7.93
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.91
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.91
Genome wide expression change in LCC2 and MCF-7 cells 7.8
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.79
Capturing the Interactome of Newly Transcribed RNA 7.79
mRNA-Seq profiling of human developing kidney 7.76
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.67
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.61
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.57
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.54
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 7.51
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.5
Mitochondrial dsRNA triggers antiviral signalling in humans 7.49
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.49
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 7.49
Gene induction by the USP6 oncogene in response to interferon 7.47
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.45
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 7.45
An RNA-centric dissection of host complexes controlling flavivirus infection 7.45
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.43
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 7.41
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.38
Differential gene expression of human melanoma cells [RNA-seq] 7.38
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.38
Identification of renal resident macrophages across species 7.36
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.34
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.29
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.21
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 7.18
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.16
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 7.04
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 7.04
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.02
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.02
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.01
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.95
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.95
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 6.91
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 6.9
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 6.9
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.83
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.83
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 6.8
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.77
RNA-sequencing in irradiated and normal A549 cells. 6.77
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.66
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.63
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.63
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 6.58
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.56
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.51
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.48
Impact of dieldrin on transcription in Jurkat T cells 6.46
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.43
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 6.41
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.39
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 6.35
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 6.33
High-throughput sequencing of pluripotent cells 6.29
Transcriptome analysis of Zika infected neural stem cells 6.27
Zika infected neural stem cells 6.27
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 6.24
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.24
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 6.23
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 6.16
K562 polyA RNA-Seq 6.11
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.11
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 6.1
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.09
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.07
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.07
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.07
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 6.06
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.04
Landscape and variation of RNA secondary structure across the human transcriptome 6.03
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 5.96
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.94
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 5.92
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.91
RIG-I and MDA5 fRIP during KSHV lytic reactivation 5.87
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.85
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.82
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.78
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.74
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.74
3’ Uridylation Expands miRNA Target Repertoire 5.7
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 5.69
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 5.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.68
The human blood-nerve barrier transcriptome 5.68
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.67
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 5.66
O-glcnAc reprograms cellular energetics 5.62
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.56
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.56
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 5.55
Effect of FGF13 depletion on the H460 cell line 5.54
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.52
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.47
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 5.44
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.41
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 5.4
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.4
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.39
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 5.33
Dynamic 3D chromosomal landscapes in acute leukemia 5.33
Gene expression analysis of human liver progenitor-like cells in culture 5.31
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.31
Metastasis in triple-negative breast cancer 5.31
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.29
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.24
BCL11B 5.23
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.22
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.21
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.18
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.18
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.18
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.15
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 5.14
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.13
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.13
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 5.1
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 5.1
A code of mono-phosphorylation modulates the function of RB. 5.09
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.07
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.06
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.06
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.05
Energy Metabolism during Anchorage-Independence 5.04
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.02
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.98
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.97
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.97
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 4.94
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.91
Human Treg IL-12 stimulation 4.87
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 4.79
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.78
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.77
RNA-Seq with and without RNase treatment in PCa cell lines 4.76
EWSR1 influences alternative splicing through direct and indirect mechanisms 4.74
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.72
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 4.69
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.67
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 4.64
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 4.64
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.63
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.63
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 4.6
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 4.6
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.56
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.53
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.49
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.44
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.43
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 4.43
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.38
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.38
Patient-derived xenograft platform for metastatic melanoma 4.36
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.32
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.32
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.31
RNA sequencing of primary human platelets and in vitro cell lines 4.26
High-throughput sequencing of PROMPT-enriched samples. 4.25
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.18
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 4.1
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.09
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.08
m6A-dependent regulation of messenger RNA stability 4.06
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 4.04
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.02
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.0
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.93
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.92
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 3.88
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.87
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.86
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.86
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.85
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.83
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.82
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.82
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.79
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.75
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.73
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.73
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.72
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.71
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.65
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.6
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.6
NAPRT activation of macrophages 3.59
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 3.53
Positively selected enhancer elements endow tumor cells with metastatic competence 3.53
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 3.52
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 3.52
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.5
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.46
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 3.42
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.27
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.27
RNA editing in nascent RNA affects pre-mRNA splicing 3.25
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.24
Ribosome profiling upon inhibition of eIF4A 3.23
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.23
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.2
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.16
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.11
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.1
SRSF1 role in cellular gene expression and splicing 3.09
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.08
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.03
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 2.89
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.88
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.87
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.83
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.83
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.81
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.75
RNA-seq of RKO cells with cTAZ KO or putback 2.74
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.74
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.74
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.72
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.63
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.61
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.6
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 2.6
Mapping interactions for the TNIP2 hub protein 2.6
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.58
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.57
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 2.56
Transcriptome-wide modulation of splicing by the exon junction complex 2.53
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.47
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.44
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.44
Comparative Analysis of Cas9 Activators Across Multiple Species 2.44
Identifying the molecular mode of action of itraconazole in colorectal cancer 2.42
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.41
Genome-wide discovery of human splicing branchpoints 2.36
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.35
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.33
Gene expression profile in breast cancer cells 2.33
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.29
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.29
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.29
Transcriptome analysis of peripheral blood monocytes 2.28
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.25
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.25
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.25
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.22
Transposon-based construction of strand-specific RNA-seq libraries 2.2
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.2
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.17
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.17
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.17
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.16
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.16
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.15
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.14
miR-93 Targets in Human Endothelial Cells 2.13
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.04
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.02
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.93
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 1.92
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.92
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.9
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 1.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.86
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.84
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.84
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.82
Gene expression analysis of human adenomas. 1.81
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.8
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.78
Activity-dependent transcriptional changes in human neurons 1.74
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.73
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.73
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.73
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.73
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.72
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.7
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.69
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.69
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.69
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 1.69
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.67
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.67
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.66
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.65
Transcriptional landscape changes during human embryonic stem cell derivation 1.65
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.58
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.56
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.54
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.54
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.52
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.51
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.47
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.44
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.44
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.43
HEK293 Heat-shock experiment 1.4
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.4
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.38
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 1.33
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.28
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.28
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.28
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.28
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 1.21
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.2
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.2
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.2
Transcription elongation regulates genome 3D structure 1.16
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.15
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.13
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.11
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.11
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 1.1
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.1
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.1
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.08
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.07
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.05
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.04
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.03
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.01
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.0
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.99
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.99
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.98
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.97
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.95
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.89
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.86
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.83
Gene expression activation in CLL mediated by MSCs contact 0.83
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.82
SLAM-seq for K562 endogenous mRNA decay 0.8
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.75
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.72
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.7
Genome wide miR-191 target profile determined by RIP and gene expression profiling 0.7
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 0.7
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.68
Induced DNA demethylation, genome instability and transcription 0.64
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.64
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.64
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.64
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.58
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.53
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.53
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.5
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.49
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.48
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.47
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.47
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.45
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.45
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.45
Metabolism as an early predictor of DPSCs aging 0.44
Global transcriptome analysis of WT versus HEB-/- hESCs 0.44
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.43
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.38
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.36
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.35
hESC neural differentiation 0.35
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.33
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.32
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.29
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.27
Transcriptome-wide response to synthetic chromatin protein PcTF 0.27
miR941 overexpression experiment 0.26
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.26
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.25
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.24
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.24
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.23
Human Treg NaCl stimulation 0.22
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.22
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 0.22
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.21
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.2
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.17
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.16
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.15
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.14
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.14
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.14
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.13
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
The role of m6A/m-RNA methylation in stress response regulation 0.1
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.1
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.1
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.09
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.09
Determining mRNA half-lives on a transcriptome-wide scale 0.08
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.08
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.08
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.07
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.05
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.04
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.04
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.02
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation